Stay updated on Nivolumab with Bevacizumab in Glioblastoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab with Bevacizumab in Glioblastoma Clinical Trial page.

Latest updates to the Nivolumab with Bevacizumab in Glioblastoma Clinical Trial page
- CheckyesterdayChange DetectedA new revision tag v3.6.2 was added and the older v3.6.0 tag was removed. This reflects a minor version update in the page's revision history.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page adds new help and navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and indicates that no participants are being recruited. The Intervention/Treatment label is updated from 'Intervention / Treatment' and the revision version changes to v3.6.0.SummaryDifference0.4%

- Check22 days agoChange DetectedThe page now displays Revision: v3.5.5, indicating an updated version is in effect. This update reflects a version control change rather than a modification to the study details or navigation.SummaryDifference0.1%

- Check43 days agoChange DetectedRevision: v3.5.4 was added, indicating a software version update in the page footer. This update does not modify the study content or visible functionality.SummaryDifference0.1%

- Check65 days agoChange DetectedThis change updates the ClinicalTrials.gov page’s UI/release revision marker from v3.5.2 to v3.5.3 without altering the displayed study details.SummaryDifference0.1%

- Check72 days agoChange DetectedSite revision updated from v3.5.0 to v3.5.2. No study content or user-facing information appears to have changed.SummaryDifference0.1%

Stay in the know with updates to Nivolumab with Bevacizumab in Glioblastoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab with Bevacizumab in Glioblastoma Clinical Trial page.